Issued Patents All Time
Showing 25 most recent of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11814443 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +2 more | 2023-11-14 |
| 11673970 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +1 more | 2023-06-13 |
| 11141433 | Therapeutic cell systems and methods for treating cancer and infectious diseases | Sivan Elloul | 2021-10-12 |
| 10988547 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +2 more | 2021-04-27 |
| 10858450 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +1 more | 2020-12-08 |
| 10407512 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +2 more | 2019-09-10 |
| 9982060 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +1 more | 2018-05-29 |
| 9968694 | Compositions and methods for non-invasive imaging | Daryl C. Drummond, Dmitri B. Kirpotin, Bart S. Hendriks, Samuel V. Agresta, Helen Lee +1 more | 2018-05-15 |
| 9913901 | Combination therapy for treating HER2-positive cancers | Victor Moyo, Bart S. Hendriks, Elena Geretti, Joseph G. Reynolds, Christopher W. Espelin | 2018-03-13 |
| 9718892 | Method of treating myocardial infarction by administering a bi-specific fusion protein | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +2 more | 2017-08-01 |
| 9610249 | Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents | Joseph G. Reynolds, Kenneth J. Olivier, Jr., Bart S. Hendriks, Stephan Klinz, Elena Geretti | 2017-04-04 |
| 9511155 | Compositions and methods for non-invasive imaging | Daryl C. Drummond, Dmitri B. Kirpotin, Bart S. Hendriks, Samuel V. Agresta, Helen Lee +1 more | 2016-12-06 |
| 9238080 | Bi-specific fusion proteins | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +2 more | 2016-01-19 |
| 9226966 | Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents | Joseph G. Reynolds, Kenneth J. Olivier, Jr., Bart S. Hendriks, Stephan Klinz, Elena Geretti | 2016-01-05 |
| 8691771 | Bi-specific fusion proteins for tissue repair | Ulrik Nielsen, Birgit Schoeberl, Brian Harms, Bryan Linggi, Matthew Onsum +1 more | 2014-04-08 |
| 6998263 | Methods of preparing and using a viral vector library | Imre Kovesdi, Duncan McVey, Joseph T. Bruder, Douglas E. Brough | 2006-02-14 |
| 6951755 | Vectors and methods for gene transfer | Imre Kovesdi, Douglas E. Brough | 2005-10-04 |
| 6756044 | Antigenic complexes and methods | Petrus W. Roelvink, Joseph T. Bruder, Imre Kovesdi | 2004-06-29 |
| 6740525 | Adenoviral capsid containing chimeric protein IX | Petrus W. Roelvink, Imre Kovesdi | 2004-05-25 |
| 6649407 | Targeting adenovirus with use of constrained peptide motifs | Petrus W. Roelvink, Imre Kovesdi | 2003-11-18 |
| 6576456 | Chimeric adenovirus fiber protein | Erik Falck-Pedersen, Petrus W. Roelvink, Joseph T. Bruder, Jason G. D. Gall, Imre Kovesdi | 2003-06-10 |
| 6465253 | Vectors and methods for gene transfer to cells | Imre Kovesdi, Douglas E. Brough | 2002-10-15 |
| 6455314 | Alternatively targeted adenovirus | Imre Kovesdi, Petrus W. Roelvink, Joseph T. Bruder | 2002-09-24 |
| 6329190 | Targetting adenovirus with use of constrained peptide motifs | Petrus W. Roelvink, Imre Kovesdi | 2001-12-11 |
| 6153435 | Nucleic acid that encodes a chimeric adenoviral coat protein | Ronald G. Crystal, Erik Falck-Pedersen, Jason G. D. Gall, Imre Kovesdi | 2000-11-28 |